Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	35.34	103.11	76.19
Graham Fair Price	2.91	47.96	46.60
PEG	537.89	10.36	-1.62
Price/Book	15.83	29.96	25.87
Price/Cash Flow	-23.36	110.64	144.36
Prices/Earnings	14.06	38.54	33.79
Price/Sales	23.94	39.37	31.77
Price/FCF	-23.36	110.64	144.36
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-4.58	0.59	0.62
Operating Margin	-10.04	0.36	0.40
ROA	-1.41	0.04	0.04
ROE	0.19	0.19	1.56
ROIC	0.09	0.07	-20.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.12	< 0.005	3933.59
Dividends QOQ	0.09	< 0.005	-93.62
EBIT QOQ	0.06	-0.15	156.37
EPS QOQ	-0.21	0.04	-82.12
FCF QOQ	-0.33	0.54	61.99
Revenue QOQ	0.04	-0.05	39.86
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	289.94	280.98	-3.09
Days Sales Outstanding (DSO)	70.62	65.45	-7.32
Inventory Turnover	0.31	0.32	3.19
Debt/Capitalization	0.66	0.68	3.35
Quick Ratio	1.16	1.35	16.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	22.46	22.93	2.12
Cash	24.66	31.82	29.01
Capex	-0.57	-0.53	6.12
Free Cash Flow	4.02	6.21	54.34
Revenue	18.29	17.45	-4.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.88	2.08	10.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.05	5.25	29.68
Naive Interpretation	Member

06 - Financial Health · Bad

Rating